We are live on
!
Find out more
RVM
RiverVest Venture Management Portfolio holdings
AUM
$6.84M
1-Year Est. Return
7.71%
This Fund
S&P 500
This Quarter
Est. Return
-16.75%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$649M
AUM Growth
-$261M
(-29%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-17.28%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$109M |
| 2 |
OTIC
Otonomy, Inc.
OTIC
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
JDR
KIM
ACM
HVM
BGC
QC
CU
PWA
RiverVest Venture Management's Q1 2021 Portfolio in Review
As of Q1 2021, RiverVest Venture Management held 5 positions worth $649M, down 29% from $910M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
RiverVest Venture Management withdrew a net $112M in Q1 2021, closing 1 position and reducing 1 holding. Its most notable exit was Otonomy, Inc., an estimated $3.25M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- RiverVest Venture Management's biggest Q1 2021 reduction was Allakos, cutting an estimated $109M.
- RiverVest Venture Management fully exited Otonomy, Inc. in Q1 2021, selling an estimated $3.25M.
- RiverVest Venture Management's ten largest holdings make up 100% of its $649M portfolio in Q1 2021.
- RiverVest Venture Management opened 0 new positions and closed 1 in Q1 2021.
- RiverVest Venture Management's portfolio value fell 29% quarter-over-quarter to $649M.
Based on RiverVest Venture Management's 13F filing for Q1 2021, filed 11 Aug 2021.